Kristijan Ramadan is the Director of the Developmental Biology & Regenerative Medicine Programme at Lee Kong Chian School of Medicine (LKCMedicine) and the Toh Kian Chui Distinguished Professor of Cancer and Stem Cell Biology at Nanyang Technological University (NTU), Singapore. He is also an Honorary Senior Research Scientist and Medical Research Council (MRC) Investigator at the Department of Oncology, University of Oxford, UK. Before joining LKCMedicine, Kristijan was a Full Professor of Molecular Medicine at the University of Oxford and an MRC Investigator at the Department of Oncology. Kristijan holds degrees in Veterinary Medicine (DVM) and veterinary pathology (MSc), as well as a PhD in biochemistry and molecular biology under the supervision of Prof Dr Ulrich Hübscher. He did his post-doctoral training at the ETH-Zürich (Swiss Federal Institute of Technology) in the group of Dr Hemmo Meyer. Between 2009 and 2013, he was Junior Group Leader and Lecturer at the Institute of Pharmacology and Toxicology-Vetsuisse, University of Zürich. In 2013, he moved to the UK to join the Department of Oncology as MRC Senior Group leader. From 2014 to 2019, he was an Associate Professor at the Department of Oncology, University of Oxford. In 2019, Kristijan was promoted to the Full Professor of Molecular Medicine at the University of Oxford. In 2024, he took a chair position in Cancer and Stem Cell Biology at LKCMedicine, NTU, Singapore. Kristijan received the Proud of Croatia Award (Croatian Hero for 2014) for his scientific co-contribution to saving the life of a young boy who had liver cancer caused by mutations in the SPRTN gene. Kristijan's research has made significant contributions to Medicine. His work has led to the codiscoveries of Chromatin-Associated Degradation, DNA-Protein Crosslink Proteolysis Repair, and Ruijs-Aalfs Syndrome (RJALS), all of which have had a profound impact on our understanding and treatment of various medical conditions, including cancer and ageing. In 2020, Kristijan was elected to the Croatian Academy of Sciences and Arts (HAZU) as a distinguished scientist in Medicine. In 2024, Nanyang Technological University awarded him the Toh Kian Chui Distinguished Cancer and Stem Cell Biology Professorship to lead a research programme and provide leadership and mentorship to take LKCMedicine to the frontiers of research.